Biology Virology
News
02 Aug 2024
Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, IMDEA Nanoscience (Madrid, Spain) and CNB-CSIC (Madrid, Spain) report in ACS Nano experiments that reveal a cycle of conformational stages that recombinant Influenza A genomes pass through during RNA synthesis.
30 Jul 2024
Applied Microbiology International has announced that it has recruited 11 new Global Ambassadors from around the world.
17 Jun 2024
Study suggests mycoviral infections affect the ecology of host oomycete
25 Jan 2024
Taiwan: Researchers from National Chung-Hsing University, Taiwan, have made a discovery in the fight against Zika virus. Their study, published in the journal “Communication Biology,” reveals that people who have previously been exposed to dengue virus and Japanese encephalitis virus may have acquired immunity against Zika virus. This finding may shed new light on vaccine strategies in countries where these viruses are common.
24 Jan 2024
This week sees the launch of the first published content in Sustainable Microbiology, the new open access journal which will apply microbiology to sustainability. The journal is published by Applied Microbiology International.
27 Oct 2023
Researchers at Kanazawa University report in the Journal of Physical Chemistry Letters high-speed atomic force microscopy studies that shed light on the possible role of the open reading frame 6 (ORF6) protein COVID19 symptoms.
19 Jan 2023
Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy can be used to assess the effectivity of spike-neutralizing antibodies for preventing COVID-19. The use of such antibodies offers a promising alternative to vaccines.
05 Jan 2023
Researchers at Hokkaido University have revealed the effects of high pathogenicity avian influenza virus infection on an Ezo red fox and a Japanese raccoon dog, linking their infection to a recorded die-off of crows.
08 Dec 2022
Giants in History: Chinese-American virologist and molecular biologist Flossie Wong-Staal (27 August 1946 – 8 July 2020) was the first scientist to clone HIV and determine the function of its genes.
06 Oct 2022
Low concentrations of cetylpyridinium chloride, an antimicrobial agent present in mouthwashes, inhibit the infectivity of four variants of SARS-CoV-2.
22 Aug 2022
Scientists show that there is a close association between clinical cases of COVID-19 and viral loads in wastewater, with the viral loads picking up to two days before the cases were detected.
05 Jul 2022
Innate immunity is activated when the pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs). We show that a liver-derived secretory protein LECT2, a hepatokine, binds to the HGF receptor MET, a proto-oncogene product, to suppress the proliferation signal of MET. LECT2 activates retinoic acid-inducible gene-I, enhancing antiviral and innate immune responses through MET. Thus, LECT2 is an anti-proliferative and immunoregulatory factor that could be a therapeutic target for viral infections and cancer.
25 May 2022
Researchers in Japan demonstrated the benefits of a new non-radioactive, neutral negative staining reagent by imaging viruses at nanometer-scale.
03 Feb 2022
Wastewater-based epidemiological tracking of COVID-19 in the Tokyo 2020 Olympic and Paralympic village showed that SARS-CoV-2 was present in areas without diagnosed individuals.
15 Dec 2021
In a recent study published in the Journal of Extracellular Vesicles researchers from Kanazawa University have visualized structural changes on the surface of SARS-CoV-2 that enable it to enter human cells.
10 Sep 2021
Researchers have identified a potential reason why lower numbers of COVID cases have appeared amongst smokers compared to non-smokers, even as other reports suggest smoking increases severity of the disease.

22 Jun 2021
GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralisation Technology (sVNT). Neutralising antibodies have been scientifically shown to play major role in preventing infection by blocking the virus from infecting the cells.
21 May 2021
Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I. Upregulating expression of this protein could strengthen the immune response in COPD patients.
19 May 2021
Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.

14 Apr 2021
On April 15, 2021, Hokkaido University and Shionogi & Co., Ltd. will start to monitor COVID-19 in Osaka Prefecture based on wastewater-based epidemiology (WBE), with the cooperation of the Prefectural Government.
13 Apr 2021
Researchers from Osaka University and Hokkaido University develop a system for analyzing mutations in SARS-CoV-2 that is much simpler and faster than existing methods.

19 Mar 2021
On March 19, 2021, Hokkaido University, Robotic Biology Institute Inc., iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) toward the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater.
11 Mar 2021
Scientists have discovered a route of introduction for High Pathogenicity Avian Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.
18 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
12 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
10 Feb 2021
In a study published in Gastroenterology – Researchers at Osaka City University and The Institute for Medical Science, The University of Tokyo, in collaboration with Brigham and Women's Hospital in Boston, report the intestinal bacterial and viral metagenome information from the fecal samples of patients with recurrent Clostridioides difficile infection (rCDI). This comprehensive analysis reveals the bacteria and phages involved in pathogenesis in rCDI, and their remarkable pathways important for the recovery of intestinal flora function.
04 Feb 2021
This article is an excerpt from the Hokkaido University research magazine “Tackling Global Issues vol.3 Fighting the menace of zoonosis" (link below).
23 Nov 2020
Taskforce will look into COVID-19 origins, leveraging expertise in One Health, outbreak investigation, virology, lab biosecurity and disease ecology.
16 Aug 2020
Researchers in Kanazawa University has recently reported their study in Nano Letters regarding a high-speed atomic force microscopy study on a biological event that happens during flu virus enters infects its host cell. The real-time visualization of influenza A hemagglutinin (HA) has enhanced the understanding of fusogenic transition of HA and its interactions with host endosomes.
Events
Sorry, nothing coming up for this discipline
Researchers
Tomohiro Mochizuki is a specially-appointed assistant professor at Earth-Life Science Institute (ELSI) - Tokyo Institute of Technology.
Dr Danielle Anderson is the Scientific Director of the Duke-NUS Medical School ABSL3 laboratory.
Giants in history
Michiaki Takahashi (17 February 1928 – 16 December 2013) was a Japanese virologist who developed the first chickenpox vaccine.
Chinese-American virologist and molecular biologist Flossie Wong-Staal (27 August 1946 – 8 July 2020) was the first scientist to clone HIV and determine the function of its genes.
Maharani Chakravorty (1937 – 2015) was one of India’s earliest molecular biologists whose research paved the way for advances in the treatment of bacterial and viral infections.